欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/3450/005
药品名称Rivaroxaban Tillomed
活性成分
    • RIVAROXABAN 15.0 mg
    • RIVAROXABAN 20.0 mg
剂型Film-coated tablet
上市许可持有人Tillomed Malta Limited Tower Business Centre 2nd Floor Tower Street Swatar
参考成员国 - 产品名称Denmark (DK)
Rivaroxaban Tillomed
互认成员国 - 产品名称
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Malta (MT)
      Treatment Initiation Pack: Rivaroxaban Tillomed 15 mg, 20 mg Film Coated Tablets
    • Germany (DE)
      Rivaroxaban Tillomed 15 mg + 20 mg Filmtabletten Starterpackung
    • Ireland (IE)
    • Italy (IT)
许可日期2024/03/14
最近更新日期2024/07/31
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase